Noom is running a horror-style ad about weight regain 18 months out.
Your biggest churn window opens a lot sooner than that. Below, that gap, plus a federal bill aimed at the management-company model and a funded clinic built around stopping a drug.
The Pulse
Noom’s new ad sells fear of weight regain at month 18.
On October 7, Fierce Pharma covered a new spot from Noom’s “Lose for Keeps” campaign. In it, a woman’s smoke detector tells her that studies show she will regain the weight in 18 months.
The ad names no source for the 18-month figure, and its claim that Noom members keep off twice as much weight after stopping a GLP-1 is Noom’s own.
Still, a national brand is now paying for media to tell your patients that stopping is where the trouble starts.
Fear of regain is an acquisition message at Noom’s scale. At yours it is a retention message, and the person you most need to reach is already on your list.
A federal bill would restrict the management-company model many telehealth brands run on.
The Stop Corporate Takeovers of Physicians Act was introduced on September 16 by Senators Warren, Wyden and Merkley, with three House Democrats. Per October 7 coverage on telehealth.org, it would bar management services organizations from controlling hiring, billing, payer contracts and revenue at the practices they serve.
It would take effect one year after enactment with no grandfathering, according to a Nixon Peabody analysis, and it sits in a Senate committee. Nothing changes today.
The coverage says it could reach the MSO structures telehealth organizations use, though the bill text does not address telehealth directly.
If your lifecycle program sits in the management company and the clinical voice sits in the practice, find out now which entity owns the sender, the list and the provider-voice copy.
Outro raised $7M to help patients taper off antidepressants.
On October 9, MobiHealthNews reported that Outro, a virtual clinic for supervised antidepressant tapering, raised $7 million in pre-seed and seed funding. Its flagship program runs in 14 states, and the money goes toward more clinicians, AI workflows for deprescribing and additional medication classes.
Investors are funding a company built around the moment a patient wants to stop.
Most telehealth lifecycles book that moment as churn. If a patient wants a supervised way off your treatment and you offer none, someone else now has funding to offer it.
The Deep Dive
Noom is paying for TV to scare people about month 18. Your churn problem sits closer to week 3.
Directionally, the first 30 days holds the biggest single block of telehealth churn, somewhere in the 40 to 60% range.
And inside that month, weeks 2 and 3 are the first real doubt point.
Fear of a bad outcome is a strong motivator, which is why Noom’s ad works. The same lever works earlier, when the patient is deciding whether to stay.
1. By week 3, the excitement is gone and the scale has not moved.
The patient started with a plan and a lot of hope.
Now there is no visible result yet, and a generic “how is it going” email does not answer the question they are actually asking: is this working?
For GLP-1 patients, appetite and food noise change before weight does. They feel something shift, see nothing on the scale, and start doubting a change that is real.
It also lands in the side-effect stretch, when nausea, GI discomfort and fatigue show up for many patients. Discomfort plus no visible result is the combination that tempts a quiet pause.
2. Send a plain-text “what to expect” email, signed by the founder.
Walk through weeks 1, 2, 3 and 4 in order, one short paragraph each:
Week 1: what the first days feel like and what is normal.
Week 2: the side effects to expect, and when to message the care team.
Week 3: appetite and food noise shift first, and weight follows.
Week 4: the first real progress check and what comes next.
Then name the one thing that runs behind schedule: the scale.
Plain text and a real signature make it read like a note from a person, not a campaign. It also cleans up after the quiz or the ad, because patients who were promised a faster timeline than treatment delivers do not blame the promise. They blame the product.
3. Pair it with a near-quit story, and key both to days on treatment.
Use a story from a real patient who almost cancelled, kept going and reached the result. Ask permission and anonymize it.
The email tells them what is normal. The story shows them someone who felt the same doubt and stayed.
Trigger both emails from days on treatment, not days since purchase. A patient who waited a week for a shipment is not on day 14 just because the order is.
Automate both, so your care team only handles the replies.
The takeaway: Noom can afford to scare people about month 18. You can afford a free email in week 3, and whatever you save there gets billed again every month after.
Quick Takes
A new sending domain started on October 21 will not be ready for Black Friday.
Warm-up takes four to eight weeks in our experience. Start on October 21 and the short end finishes on November 18, nine days before Black Friday. The long end finishes on December 16, after Cyber Monday.
Engagement on your old domain does not transfer to the new one. Build the first segment from people who opened or clicked mail from that exact domain, plus existing customers, and move your welcome and post-purchase flows onto it first.
Widen only when opens clear 35 to 40%.
One Thing to Try
Pull your cancellations from the last 90 days and sort them by days on treatment, not by calendar date.
Count how many fall between day 10 and day 25. If that stretch holds more cancellations than any other two-week window, the week 3 pair is your next build.
Then draft the what-to-expect email: one short paragraph for each of weeks 1 to 4, and one line saying the scale is the thing that runs behind schedule.
The pull and the draft take under an hour. The near-quit story can wait until next week, once support has found you a patient who agrees to share theirs.
If retention is your biggest revenue leak, that’s what we fix. growthtrigger.xyz
Reply to this with your biggest retention challenge. I read and respond to every single one.
